av/amphastar-pharmaceuticals--big.svg

COM:AMPHASTAR

Amphastar Pharmaceuticals

  • Stock

Last Close

47.39

25/09 14:37

Market Cap

1.83B

Beta: -

Volume Today

26.85K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
60.65M
-
76.12M
25.52%
76.50M
0.49%
75.21M
1.69%
71.68M
4.69%
66.47M
7.28%
89.91M
35.28%
103.67M
15.30%
94.82M
8.53%
98.20M
3.56%
average payables
19.02M
-
15.27M
19.72%
12.02M
21.31%
15.03M
25.11%
16.41M
9.17%
52.02M
216.97%
82.23M
58.07%
86.28M
4.92%
92.52M
7.24%
86.89M
6.09%
average receivables
32.64M
-
25.07M
23.20%
28.30M
12.88%
30.14M
6.49%
34.42M
14.20%
47.12M
36.92%
48.95M
3.88%
56.04M
14.48%
72.66M
29.66%
83.95M
15.54%
book value per share
31.44
-
6.72
78.63%
6.57
2.16%
7.26
10.40%
7.32
0.83%
7.17
2.06%
8.12
13.29%
8.55
5.37%
9.33
9.03%
10.89
16.77%
capex per share
-2.29
-
-0.49
78.64%
-0.36
26.95%
-0.47
32.03%
-0.76
61.55%
-1.01
32.53%
-0.88
12.33%
-0.72
18.63%
-0.57
20.16%
-0.50
13.86%
capex to depreciation
-1.40
-
-1.42
1.38%
-1.21
14.65%
-1.47
21.24%
-2.27
54.88%
-2.83
24.64%
-1.97
30.58%
-1.34
31.66%
-1.03
23.67%
-0.84
18.52%
capex to operating cash flow
-0.59
-
-0.97
65.15%
-1.50
54.29%
-0.55
63.09%
-0.90
61.43%
-1.23
36.91%
-1.00
18.81%
-0.59
40.59%
-0.28
52.61%
-0.27
3.81%
capex to revenue
-0.08
-
-0.10
22.23%
-0.06
34.50%
-0.08
31.34%
-0.15
74.40%
-0.16
8.70%
-0.13
18.85%
-0.10
24.93%
-0.06
35.19%
-0.05
23.20%
cash per share
6.70
-
1.65
75.33%
1.50
9.33%
1.61
7.21%
1.48
7.87%
1.92
29.88%
1.82
5.47%
2.25
23.59%
2.86
27.40%
3.62
26.55%
days of inventory on hand
178.80
-
188.76
5.57%
148.09
21.55%
192.81
30.20%
155.42
19.39%
134.82
13.26%
211.79
57.10%
171.15
19.19%
142.31
16.85%
151.16
6.21%
days payables outstanding
52.12
-
23.30
55.30%
29.07
24.79%
39.16
34.69%
40.63
3.77%
170.01
318.41%
147.68
13.13%
168.80
14.30%
137.31
18.66%
122.93
10.47%
days sales outstanding
42.93
-
40.11
6.58%
48.57
21.11%
38.33
21.08%
63.88
66.63%
64.67
1.25%
51.73
20.01%
69.27
33.90%
65.81
4.99%
65.08
1.10%
debt to assets
0.09
-
0.11
18.17%
0.11
6.14%
0.09
16.29%
0.10
17.61%
0.10
5.73%
0.11
16.09%
0.11
6.11%
0.16
46.25%
0.14
11.30%
debt to equity
0.13
-
0.16
21.22%
0.14
10.30%
0.11
17.62%
0.14
22.02%
0.15
8.05%
0.17
15.66%
0.17
4.29%
0.23
40.49%
0.19
17.40%
dividend yield
0.11
-
0.03
70.34%
0.01
61.52%
0.02
-
earnings yield
0.17
-
-0.02
112.96%
-0.00
80.17%
0.01
389.27%
0.01
59.67%
-0.01
222.30%
0.05
968.87%
0.00
97.85%
0.06
4,713.59%
0.07
20.34%
0.04
37.54%
enterprise value
48.59M
-
462.99M
852.93%
614.82M
32.79%
801.18M
30.31%
868.66M
8.42%
887.14M
2.13%
899.22M
1.36%
920.56M
2.37%
1.09B
18.52%
1.31B
19.78%
enterprise value over ebitda
1.55
-
-27.07
1,848.71%
150.65
656.58%
51.06
66.11%
-140.54
375.26%
-102.88
26.80%
-23.06K
22,311.48%
84.04
100.36%
15.61
81.42%
12.16
22.13%
ev to operating cash flow
1.57
-
21.99
1,305.14%
57.56
161.73%
20.78
63.90%
22.15
6.63%
23.23
4.85%
21.53
7.30%
16.08
25.34%
11.13
30.74%
14.65
31.62%
ev to sales
0.21
-
2.20
939.96%
2.44
11.12%
3.14
28.45%
3.62
15.19%
3.01
16.76%
2.79
7.34%
2.63
5.67%
2.49
5.28%
2.62
5.09%
free cash flow per share
1.59
-
0.01
99.17%
-0.12
1,005.51%
0.38
417.21%
0.09
76.45%
-0.19
308.36%
0.00
102.37%
0.50
11,196.20%
1.48
196.64%
1.34
9.12%
2.60
93.40%
free cash flow yield
0.18
-
0.00
99.38%
-0.01
838.79%
0.02
345.05%
0.00
77.46%
-0.01
301.45%
0.00
102.45%
0.02
10,735.59%
0.06
156.14%
0.05
24.46%
0.04
12.38%
graham net net
2.70
-
0.48
82.06%
0.74
52.31%
0.76
2.69%
0.31
59.28%
0.30
3.68%
0.33
10.56%
0.45
37.94%
0.34
24.86%
1.67
389.74%
graham number
32.39
-
6.21
80.83%
3.03
51.23%
6.16
103.32%
4.01
34.83%
4.47
11.30%
13.79
208.89%
2.12
84.64%
16.52
679.62%
21.47
30.02%
income quality
2.62
-
-1.97
175.19%
-3.83
94.77%
3.66
195.53%
8.70
137.56%
-5.73
165.93%
0.90
115.66%
52.20
5,713.11%
1.55
97.03%
0.98
36.96%
1
2.47%
intangibles to total assets
0.12
-
0.11
7.80%
0.10
6.44%
0.12
15.00%
0.10
15.59%
0.08
17.10%
0.07
14.81%
0.06
8.23%
0.06
10.04%
0.05
13.16%
0
100%
interest coverage
18.26
-
-29.53
261.74%
-6.99
76.33%
15.32
319.27%
-1.08
107.07%
-35.49
3,174.98%
-0.33
99.08%
-38.04
11,506.29%
48.74
228.14%
42.66
12.47%
interest debt per share
4.14
-
1.06
74.50%
0.94
11.36%
0.85
8.78%
1.04
21.87%
1.09
4.50%
1.42
30.63%
1.44
1.23%
2.21
53.62%
2.15
2.64%
inventory turnover
2.04
-
1.93
5.28%
2.46
27.46%
1.89
23.20%
2.35
24.06%
2.71
15.29%
1.72
36.35%
2.13
23.75%
2.56
20.26%
2.41
5.85%
invested capital
0.13
-
0.16
21.22%
0.14
10.30%
0.11
17.62%
0.14
22.02%
0.15
8.05%
0.17
15.66%
0.17
4.29%
0.23
40.49%
0.19
17.40%
market cap
70M
-
487.12M
595.89%
639.80M
31.34%
835.81M
30.64%
887.10M
6.14%
923.26M
4.08%
906.28M
1.84%
945.93M
4.38%
1.11B
17.63%
1.36B
22.26%
3.28B
140.97%
net current asset value
85.77M
-
90.49M
5.50%
81.31M
10.14%
85.61M
5.29%
70.44M
17.72%
71.14M
0.99%
95.80M
34.67%
97.17M
1.43%
92.11M
5.20%
164.99M
79.12%
net debt to ebitda
-0.68
-
1.41
306.77%
-6.12
533.85%
-2.21
63.94%
2.98
235.16%
4.19
40.44%
181.03
4,221.18%
-2.32
101.28%
-0.31
86.60%
-0.50
60.41%
net income per share
1.48
-
-0.25
117.20%
-0.06
75.69%
0.23
474.45%
0.10
57.88%
-0.12
226.49%
1.04
942.24%
0.02
97.76%
1.30
5,474.77%
1.88
44.78%
2.60
37.87%
operating cash flow per share
3.88
-
0.50
87.07%
0.24
52.65%
0.85
257.72%
0.85
0.07%
0.82
3.20%
0.89
7.98%
1.22
36.96%
2.05
68.47%
1.84
10.44%
2.60
41.28%
payables turnover
7.00
-
15.67
123.73%
12.56
19.87%
9.32
25.76%
8.98
3.63%
2.15
76.10%
2.47
15.12%
2.16
12.51%
2.66
22.94%
2.97
11.70%
receivables turnover
8.50
-
9.10
7.04%
7.51
17.43%
9.52
26.71%
5.71
39.99%
5.64
1.23%
7.06
25.02%
5.27
25.32%
5.55
5.25%
5.61
1.12%
research and ddevelopement to revenue
0.14
-
0.14
6.04%
0.15
9.10%
0.16
9.57%
0.18
11.96%
0.20
8.07%
0.21
9.34%
0.19
10.03%
0.14
27.57%
0.15
7.66%
0.12
17.05%
return on tangible assets
0.04
-
-0.03
177.65%
-0.01
74.21%
0.03
450.67%
0.01
60.55%
-0.01
210.60%
0.09
836.45%
0.00
97.93%
0.10
5,186.11%
0.13
32.08%
revenue per share
28.71
-
5.02
82.53%
5.59
11.52%
5.62
0.52%
5.21
7.37%
6.35
21.93%
6.86
8.03%
7.44
8.40%
9.16
23.20%
10.28
12.17%
11.19
8.91%
roe
0.05
-
-0.04
180.49%
-0.01
75.15%
0.03
439.17%
0.01
58.22%
-0.02
229.16%
0.13
843.46%
0.00
97.88%
0.14
5,013.10%
0.17
23.99%
roic
0.04
-
-0.03
176.72%
-0.01
83.08%
0.03
646.79%
-0.01
121.46%
-0.02
133.86%
-0.00
99.57%
-0.01
10,553.75%
0.06
920.98%
0.10
69.47%
sales general and administrative to revenue
0.13
-
0.17
22.65%
0.17
0.23%
0.16
0.65%
0.19
12.91%
0.17
8.54%
0.16
7.87%
0.14
7.68%
0.12
18.41%
0.09
23.14%
0.09
3.79%
shareholders equity per share
31.44
-
6.72
78.63%
6.57
2.16%
7.26
10.40%
7.32
0.83%
7.17
2.06%
8.12
13.29%
8.55
5.37%
9.33
9.03%
10.89
16.77%
stock based compensation to revenue
0.03
-
0.04
43.96%
0.05
15.55%
0.06
16.33%
0.07
20.03%
0.06
20.43%
0.05
5.22%
0.06
9.21%
0.04
27.14%
0.04
16.15%
tangible asset value
211.38M
-
239.29M
13.21%
255.61M
6.82%
278.95M
9.13%
292.19M
4.75%
322.09M
10.23%
386.38M
19.96%
408.11M
5.62%
406.65M
0.36%
491.36M
20.83%
tangible book value per share
26.42
-
5.70
78.42%
5.69
0.32%
6.15
8.14%
6.34
3.08%
6.94
9.55%
8.22
18.46%
8.68
5.50%
8.51
1.90%
10.12
18.90%
working capital
107.57M
-
135.40M
25.87%
115.98M
14.34%
123.48M
6.47%
120.59M
2.34%
113.51M
5.87%
165.23M
45.57%
167.48M
1.36%
214.31M
27.96%
283.46M
32.27%

All numbers in (except ratios and percentages)